ReviewAdvances in experimental medicine and biology2025
Innate Immune Response to Viral Infection.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Innate immune transcriptomic remodeling across clinical stages of bovine leukemia virus infection.Virus genes · 2026Article
- Review
- A Viral Protein Antagonist for Both AID and APOBEC3.Viruses · 2026Review
- Role of autophagy in antiviral innate immunity.Cellular & molecular biology letters · 2026Review
- Protease Inhibitors and Innate Immune Agonists as Antiviral Strategies Against Dengue and Zika Viruses.Pathogens (Basel, Switzerland) · 2026Review
- Cutaneous-Tropism Viruses: Unraveling Pathogenetic Mechanisms and Immunoprophylactic Strategies.Life (Basel, Switzerland) · 2026Review
- PulmonaromFrontiers in cellular and infection microbiology · 2026Article
- The gut virome and regulatory T cell axis in health and systemic disease.Microbiome research reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The innate immune system serves as the body's primary defence against all pathogen infections, including viruses. It rapidly detects and responds to viral components, enabling an effective reaction at each stage of the viral replication cycle. This chapter explores how the innate immune system utilises pattern recognition receptors, such as Toll-like receptors and RIG-I-like receptors, to identify viral structures like capsid proteins and viral nucleic acids. The activation of these receptors triggers the release of type I interferons, particularly IFN-α and IFN-β, as well as other cytokines and chemokines. These molecules are crucial in inhibiting viral replication and inducing an antiviral state in neighbouring cells. Furthermore, the cytokines and chemokines facilitate the recruitment of key innate immune cells such as macrophages, dendritic cells, and natural killer cells, which enhance the overall immune response and directly eliminate infected cells. This chapter provides a comprehensive understanding of the complex interplay between viral pathogens and the host immune system. It also examines the antiviral role of the complement system and the transition from innate to adaptive immunity, a shift often necessitated by prolonged viral replication or sophisticated immune evasion strategies employed by viruses. By detailing these interactions and emphasising the crucial roles of interferons and immune evasion strategies, this chapter highlights the importance of early innate immune responses in controlling infections.
Indexed as
Identifiers
40622544What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.